Template:Zollinger-Ellison syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(17 intermediate revisions by 6 users not shown)
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Zollinger-Ellison syndrome(patient information)|Patient Info]]
[[Zollinger-Ellison syndrome (patient information)|Patient Information]]
|-  
|-  
!
!
Line 27: Line 27:


|- bgcolor="Pink"
|- bgcolor="Pink"
!
[[Zollinger-Ellison syndrome historical perspective|Historical Perspective]]
|-
!


[[Zollinger-Ellison syndrome historical perspective|Historical Perspective]]
|- bgcolor="Pink"
!
[[Zollinger-Ellison syndrome classification|Classification]]
|-  
|-  
!
!
Line 40: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Zollinger-Ellison syndrome epidemiology and demographics|Epidemiology & Demographics]]
[[Zollinger-Ellison syndrome causes|Causes]]
|-  
|-  
!
!
Line 46: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Zollinger-Ellison syndrome risk factors|Risk Factors]]
[[Zollinger-Ellison syndrome differential diagnosis|Differentiating Zollinger-Ellison syndrome from other Diseases]]
|-  
|-  
!
!
Line 52: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Zollinger-Ellison syndrome screening|Screening]]
[[Zollinger-Ellison syndrome epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 58: Line 64:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Zollinger-Ellison syndrome causes|Causes of Zollinger-Ellison]]
[[Zollinger-Ellison syndrome risk factors|Risk Factors]]
|-  
|-  
!
!
Line 64: Line 70:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Zollinger-Ellison syndrome differential diagnosis|Differentiating Zollinger-Ellison syndromefrom other Diseases]]
[[Zollinger-Ellison syndrome screening|Screening]]
|-  
|-  
!
!
Line 70: Line 76:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Zollinger-Ellison syndrome natural history|Natural History, Complications & Prognosis]]
[[Zollinger-Ellison syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 82: Line 88:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Zollinger-Ellison syndrome history and symptoms|History & Symptoms]]
[[Zollinger-Ellison syndrome diagnostic study of choice|Diagnostic Study of Choice]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Zollinger-Ellison syndrome history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 94: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Zollinger-Ellison syndrome laboratory tests|Lab Tests]]
[[Zollinger-Ellison syndrome laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 106: Line 118:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Zollinger-Ellison syndrome chest x ray|Chest X Ray]]
[[Zollinger-Ellison syndrome x ray|X-ray]]
|-  
|-  
!
!
Line 112: Line 124:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Zollinger-Ellison syndrome CT|CT]]
[[Zollinger-Ellison syndrome echocardiography and ultrasound|Echocardiography and Ultrasound]]
|-  
|-  
!
!
Line 118: Line 130:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Zollinger-Ellison syndrome MRI|MRI]]
[[Zollinger-Ellison syndrome CT scan|CT scan]]
|-  
|-  
!
!
Line 124: Line 136:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Zollinger-Ellison syndrome echocardiography or ultrasound|Echocardiography or Ultrasound]]
[[Zollinger-Ellison syndrome MRI|MRI]]
|-  
|-  
!
!
Line 139: Line 151:
|-  
|-  
!
!
|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!
Line 161: Line 172:
!
!
[[Zollinger-Ellison syndrome primary prevention|Primary Prevention]]
[[Zollinger-Ellison syndrome primary prevention|Primary Prevention]]
|-  
|-
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Zollinger-Ellison syndrome secondary prevention|Secondary Prevention]]
[[Zollinger-Ellison syndrome secondary prevention|Secondary Prevention]]
|-  
|-
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Zollinger-Ellison syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Zollinger-Ellison syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Zollinger-Ellison syndrome future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!  
|- bgcolor="CadetBlue"
!
Case Studies
|-
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Zollinger-Ellison syndrome future or investigational therapies|Future or Investigational Therapies]]
[[Zollinger-Ellison syndrome case study one|Case #1]]
|-  
|-  
!  
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "

Latest revision as of 16:04, 19 September 2019